litaba
Litaba

Daiichi Sankyo e Phatlalatsa Liphetho tsa Teko ea Booster Vaccination

Tokyo, Japan - (November 15, 2022) - Daiichi Sankyo (TSE: 4568) kajeno o phatlalalitse hore tekong ea tlhahlobo ea katleho le polokeho ea ente ea booster ka DS-5670, ente ea mRNA khahlano le lefu le tšoaetsanoang la coronavirus (COVID-19). -19) e ntse e ntlafatsoa ke Daiichi Sankyo (kamora mona, teko ea ente ea booster), pheletso ea mantlha e fihletsoe.Teko ea ente ea booster e kenyelelitse batho ba ka bang 5,000 ba Majapane ba phetseng hantle le batho ba seng ba hōlile ba neng ba qetile letoto la mantlha (litekanyetso tse peli) tsa liente tsa mRNA tse amohetsoeng Japane bonyane likhoeli tse tšeletseng pele ho ngolisoa.Ka Pherekhong 2022, teko e ile ea qalisoa e le teko ea mohato oa 1/2/3 molemong oa ho lekola katleho le polokeho ea ente ea booster ka DS-5670 ho sebelisoa liente tsa mRNA tse amohetsoeng Japane joalo ka taolo.GMFR ea ho fokotsa li-antibody titer khahlano le SARS-CoV-2 (mathata a pele) maling libeke tse 'ne ka mor'a ente ea booster, pheletso ea mantlha ea teko ea ente ea booster, e bonts'itse lintlha tse phahameng le ho se be tlase ha DS-5670 ho liente tsa mRNA. original strain) e amohetsoeng Japane, ho fihlela sepheo se reriloeng.Ha ho matshwenyeho a polokeho a tsebisitsweng.Liphetho tse felletseng tsa teko ea ente ea booster li tla hlahisoa likopanong tsa thuto le lipampiring tsa lipatlisiso.Ho ipapisitsoe le liphetho tsa liteko, Daiichi Sankyo o tla tsoelapele ka boitokisetso ba ts'ebeliso e ncha ea moriana oa ente ea mRNA ka Pherekhong 2023. Ho feta moo, Daiichi Sankyo e rera ho etsa liteko tsa tleliniki tsa liente tsa bivalent tsa mofuta oa pele le mefuta ea Omicron khahlano le coronavirus e ncha, e tsoelang pele ho fetoha.Daiichi Sankyo o tla ikitlaelletsa ho matlafatsa nts'etsopele ea ente ea mRNA le sistimi ea tlhahiso ho netefatsa phepelo e tsitsitseng ka linako tse tloaelehileng hammoho le phano ea kapele ea liente ha ho hlaha mafu a tšoaetsanoang a hlahang le a hlaha hape.

Mabapi le DS-5670 DS-5670 ke ente ea mRNA khahlano le COVID-19 e sebelisang theknoloji e ncha ea ho fana ka nucleic acid e fumanoeng ke Daiichi Sankyo, e etselitsoeng ho hlahisa li-antibodies khahlano le domain binding domain (RBD) ea protheine ea spike ea "coronavirus" e ncha, ka hona. e lebelletsoeng ho ba le thibelo e lakatsehang khahlano le polokeho ea COVID-19 le 2.Ho feta moo, Daiichi Sankyo e ikemiselitse ho fumana liente tsa mRNA tse ka ajoa ka har'a mocheso oa sehatsetsing (2-8°C)

img1

Nako ea poso: Dec-17-2022